You have 9 free searches left this month | for more free features.

Hemoglobinopathies

Showing 1 - 25 of 138

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sickle Cell Hemoglobinopathies and Bone Health

Active, not recruiting
  • Sickle Cell Disease
  • Sickle Cell Trait
  • Healthy volunteers without SCT
  • +2 more
  • Farmington, Connecticut
    UConn Health
Nov 1, 2022

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Recruiting
  • Sickle Cell Disease
  • +3 more
  • GWAS
  • Boston, Massachusetts
  • +24 more
Apr 4, 2023

Hemoglobinopathies, Thalassemia, Sickle Cell Disease Trial in Banha (Hemoglobinopathy Nursing Program)

Completed
  • Hemoglobinopathies
  • +3 more
  • Hemoglobinopathy Nursing Program
  • Banhā, Other, Egypt
    Benha University
May 21, 2022

Hemoglobinopathies and Rare Inherited Anemia and Covid 19

Recruiting
  • Haemoglobinopathies
    • Genova, Italy
    • +1 more
    May 4, 2022

    Alpha Thalassemia Hemoglobin H Constant Spring, Hemoglobinopathies, Hereditary Diseases Trial in Nanning (RM-004)

    Recruiting
    • Alpha Thalassemia Hemoglobin H Constant Spring
    • +2 more
    • RM-004
    • Nanning, Guangxi, China
      The 923rd Hospital of Joint Logistics Support Force of People's
    Oct 25, 2023

    Screening for Hemoglobinopathies in Pregnant Women

    Recruiting
    • Hemoglobinopathies
    • Review of routine lab data
    • Basel, Switzerland
      Frauenklinik University Hospital Basel
    Oct 13, 2021

    Total Splenectomy vs Partial Splenectomy in Non-malignant

    Not yet recruiting
    • Splenectomy; Status
      • Montpellier, France
        University hospital of Montpellier
      Dec 22, 2021

      Alpha Thalassemia Major, Hemoglobinopathy; With Thalassemia, Hemoglobinopathies Trial in San Francisco (in utero hematopoietic

      Enrolling by invitation
      • Alpha Thalassemia Major
      • +8 more
      • in utero hematopoietic stem cell transplantation
      • San Francisco, California
        University of California
      Oct 28, 2022

      Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)

      Recruiting
      • Beta-Thalassemia
      • +4 more
      • CTX001
      • Nashville, Tennessee
      • +5 more
      Feb 2, 2023

      Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)

      Recruiting
      • Sickle Cell Disease
      • +4 more
      • CTX001
      • Philadelphia, Pennsylvania
      • +3 more
      Jan 24, 2023

      Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)

      Active, not recruiting
      • Sickle Cell Disease
      • Hemoglobinopathies
      • Nashville, Tennessee
        Vanderbilt-Ingram Cancer Center
      Dec 20, 2021

      Women With Heterozygous Hemoglobinopathies

      Completed
      • Heterozygous Haemoglobinopathy
      • pregnancy outcome
      • Basel, Switzerland
      • +1 more
      Jun 30, 2021

      Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

      Recruiting
      • Non Malignant Diseases
      • +2 more
      • RIC: Distal Campath
      • +2 more
      • Philadelphia, Pennsylvania
        The Children's Hospital of Philadelphia
      Mar 8, 2022

      Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)

      Recruiting
      • Transfusion Dependent Beta Thalassemia
      • +3 more
      • EDIT-301
      • Oakland, California
      • +3 more
      Jan 3, 2023

      Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

      Not yet recruiting
      • Beta-Thalassemia
      • +6 more
      • CTX001
      • (no location specified)
      Jul 26, 2022

      STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN

      Recruiting
      • Malignacy, Hemoglobinopathie
        • Cagliari, Italy
          Azienda Ospedaliera Universitaria Di Cagliari
        Mar 18, 2022

        AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

        Recruiting
        • AML
        • +8 more
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        May 13, 2022

        Oxidative Stress and Iron Overload in Abnormal Haemoglobinopathy

        Not yet recruiting
        • Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
          • (no location specified)
          Oct 16, 2022

          Sickle Cell Disease, Beta Thalassemia-Major Trial in New Hyde Park (alemtuzumab (Campath IH), Fludarabine, Melphalan)

          Completed
          • Sickle Cell Disease
          • Beta Thalassemia-Major
          • alemtuzumab (Campath IH)
          • +6 more
          • New Hyde Park, New York
            Cohen Children's Medical Center of New York
          Jul 30, 2021

          Hemoglobinopathies Trial (transcranial doppler)

          Not yet recruiting
          • Hemoglobinopathies
          • transcranial doppler
          • (no location specified)
          Mar 12, 2021

          Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem

          Active, not recruiting
          • Hematologic Malignancies
          • +7 more
          • San Francisco, California
            University of California, San Francisco
          Feb 28, 2022

          Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

          Not yet recruiting
          • Acute Lymphoblastic Leukemia in Remission
          • +10 more
          • CliniMACS
          • Houston, Texas
          • +1 more
          Dec 8, 2022

          Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

          Recruiting
          • Sickle Cell Disease
          • +4 more
          • Duarte, California
            City of Hope Medical Center
          Jul 6, 2022

          Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

          Active, not recruiting
          • Beta-Thalassemia
          • +4 more
          • CTX001
          • Stanford, California
          • +11 more
          Nov 30, 2022

          Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,

          Recruiting
          • Severe Sickle Cell Disease
          • +5 more
          • RIC regimen
          • GVHD prophylaxis regimen
          • New Haven, Connecticut
          • +1 more
          Feb 4, 2022